atibody engineering
TRANSCRIPT
Cont.... • In recent years, antibodies have become increasingly
accepted as therapeutics for human diseases, particularly for cancer, viral infection and autoimmune disorders.
• Monoclonal antibodies (Mabs) have been used as diagnostic and analytical reagents since hybridoma technology was invented in 1975.
• “man-made antibodies.” was named by Cesar Milstein, who was one of the inventors of monoclonal antibody technology.
• Until the late 1980’s, antibody technology relied primarily on animal immunization and the expression of engineered antibodies.
• Production of human Mab.
• Make mouse Ab more “human-like”
• Production of small Ab fragments.
SOLUTIONS
HUMANIZED ANTIBODIES
FR1 FR2 FR3 FR4
CDR1 CDR2 CDR3
CONSTANT
CONSTANT
CONSTANTFR1 FR2 FR3 FR4
CDR1 CDR2 CDR3
Mouse
Human
Humanized
CHIMERIC/HUMANIZED.Reduce the HAMA response.
.Maintain effector functions.
.Increase the half life of the antibody.
.Maintain binding affinity.
.Easy to construct.
.HAMA Response.
•Loss of effector functions.
Making the antibody more “human-like”. (the cutting and pasting)
Production of human Mab’s.
Chimeric Ab’s Humanized Ab’s
Hybridoma
Phage Display
Transgenic/SCID Mice
HUMAN HYBRIDOMAS
. Unstable hybridomas.
.Small number of human B-cells in peripheral blood.
. Obtaining antigen-reactive human B-cells.
Heteromyeloma
fusion
In vitro immunization
MICE
SCIDTransgenic
Reconstituted with human peripheral blood
Containing human immunoglobulin genes.
Reduce the size of Antibody. Production of
antibody fragments.
Simplifying the expression/production of antibodies.